Literature DB >> 25447268

Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?

Mariama K Cherif1, Guillaume S Sanou2, Edith C Bougouma3, Amidou Diarra3, Alphonse Ouédraogo3, Amagana Dolo4, Marita Troye-Blomberg5, David R Cavanagh6, Michael Theisen7, David Modiano8, Sodiomon B Sirima3, Issa Nebié9.   

Abstract

In the present study, the influences of FcγRIIA polymorphism on susceptibility to malaria and antibody responses to Plasmodium falciparum antigens were analyzed in children. We recruited 96 healthy children between 3 and 10 years at the beginning of the high transmission season and we followed up for 5 months through the high transmission season to assess the parasitological, immunological and genetic endpoints in relation to clinical malaria status. There was a similar distribution of homozygous and heterozygous individuals carrying the FcγRIIA-131R/R and FcγRIIA-131R/H allele, whereas the number of FcγRIIA-131H/H homozygous individuals was lower. P. falciparum infection frequency was not associated with the FcγRIIa-131R/H polymorphism. Only IgG antibody responses to GLURP R0 showed a significant association between antibody levels and FcγRIIA polymorphism (p=0.02). IgG levels to MSP2a were significantly higher in children who did not experience any clinical malaria episode compared to those who experienced at least one malaria episode (p=0.019). Cytophilic and non-cytophylic IgG subclass levels were higher in children without malaria than those who experienced at least one malaria episode. This difference was statistically significant for IgG1 to MSP3 (p=0.003) and to MSP2a (p=0.006); IgG3 to MSP2a (p=0.007) and to GLURP R0 (p=0.044); IgG2 to MSP2b (p=0.007) and IgG4 to MSP3 (p=0.051) and to MSP2a (p=0.049). In this study, homozygous carriers of the FcγRIIA-131R/R allele had higher malaria-specific antibody levels compare to the heterozygous carriers FcγRIIA-131R/H alleles and to homozygous carriers of FcγRIIA-131H/H alleles. The pre-existing antibodies responses were related to a reduced subsequent risk of clinical malaria.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical malaria outcome; FcγRIIA polymorphism; IgG and IgG subclass responses

Mesh:

Substances:

Year:  2014        PMID: 25447268     DOI: 10.1016/j.actatropica.2014.09.019

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  5 in total

1.  Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.

Authors:  Lilian Rose Pratt-Riccio; Daiana De Souza Perce-Da-Silva; Josué Da Costa Lima-Junior; Evelyn Kety Pratt Riccio; Marcelo Ribeiro-Alves; Fátima Santos; Mercia Arruda; Daniel Camus; Pierre Druilhe; Joseli Oliveira-Ferreira; Cláudio Tadeu Daniel-Ribeiro; Dalma Maria Banic
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

2.  Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.

Authors:  Bright Adu; Mariama K Cherif; Samuel Bosomprah; Amidou Diarra; Fareed K N Arthur; Emmanuel K Dickson; Giampietro Corradin; David R Cavanagh; Michael Theisen; Sodiomon B Sirima; Issa Nebie; Daniel Dodoo
Journal:  Malar J       Date:  2016-02-27       Impact factor: 2.979

3.  Major transcriptional changes observed in the Fulani, an ethnic group less susceptible to malaria.

Authors:  Jaclyn E Quin; Ioana Bujila; Mariama Chérif; Guillaume S Sanou; Manijeh Vafa Homann; Ying Qu; Anna Rolicka; Sodiomon B Sirima; Mary A O'Connell; Andreas Lennartsson; Marita Troye-Blomberg; Issa Nebie; Ann-Kristin Östlund Farrants
Journal:  Elife       Date:  2017-09-19       Impact factor: 8.140

4.  Genetic variation in the immune system and malaria susceptibility in infants: a nested case-control study in Nanoro, Burkina Faso.

Authors:  Hamatandi Magloire Natama; Eduard Rovira-Vallbona; Meryam Krit; Pieter Guetens; Hermann Sorgho; M Athanase Somé; Maminata Traoré-Coulibaly; Innocent Valéa; Petra F Mens; Henk D F H Schallig; Dirk Berkvens; Luc Kestens; Halidou Tinto; Anna Rosanas-Urgell
Journal:  Malar J       Date:  2021-02-16       Impact factor: 2.979

Review 5.  What will studies of Fulani individuals naturally exposed to malaria teach us about protective immunity to malaria?

Authors:  Marita Troye-Blomberg; Charles Arama; Jaclyn Quin; Ioana Bujila; Ann-Kristin Östlund Farrants
Journal:  Scand J Immunol       Date:  2020-10       Impact factor: 3.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.